natgillin/translations-raw huggingface dataset:
Common (may affect up to 1 in 10 people): bleeding at the injection or puncture site nosebleeds genitourinary bleeding (you may notice blood in your urine) bruising gastro-intestinal bleeding (e.g. bleeding from the stomach or bowel) 
Pogosti (pojavijo se lahko pri največ 1 od 10 bolnikov): krvavitev na mestu vboda ali punkcije, krvavitve iz nosu, krvavitev v rodilih ali sečilih (opazite lahko kri v seču), modrice, krvavitev v prebavilih (npr. krvavitev v želodcu ali črevesu).
pericarditis, pulmonary oedema - uncommon: cardiac arrest, mitral valve incompetence, pericardial effusion, venous thrombosis, 
pljučni edem, - občasni: srčni zastoj, inkompetenca mitralne zaklopke, izliv v perikardij, venska tromboza,
one vial of 10,000 units Metalyse powder and one pre-filled syringe containing 10 ml water for injections. 
- eno vialo z 10.000 enotami praška zdravila Metalyse in - eno napolnjeno brizgo z 10 ml vode za injekcije.
Metalyse is a powder and solvent for solution for injection. 
Zdravilo Metalyse je v obliki praška in vehikla za pripravo raztopine za injiciranje.
METHOD AND ROUTE(S) OF ADMINISTRATION For intravenous use after reconstitution with 10 ml solvent 
POSTOPEK IN POT(I) UPORABE ZDRAVILA za intravensko uporabo po pripravi z 10 ml vehikla
METHOD AND ROUTE(S) OF ADMINISTRATION For intravenous use after reconstitution with 8 ml solvent 
POSTOPEK IN POT(I) UPORABE ZDRAVILA za intravensko uporabo po pripravi z 8 ml vehikla
Composite death, shock, congestive heart failure, re-infarction 
Sestavljeni dogodek: smrt, šok, zastojno srčno popuščanje, ponovni infarkt Umrljivost iz vseh vzrokov
What Metalyse contains 
Kaj vsebuje zdravilo Metalyse
The use of rigid catheters as well as intramuscular injections and non-essential handling of the patient should be avoided during treatment with tenecteplase. 
Med zdravljenjem s tenekteplazo se je treba izogibati uporabi togih katetrov, intramuskularnih injekcij in vseh ukrepov, ki niso nujno potrebni.
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2). 
B. POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE Predpisovanje in izdaja zdravila je le na recept s posebnim režimom (glejte Prilogo I: Povzetek glavnih značilnosti zdravila, poglavje 4.2).
No sustained antibody formation to the tenecteplase molecule has been observed after treatment. 
Po zdravljenju niso zasledili trajnega nastajanja protiteles proti molekuli tenekteplaze.
Your doctor will give you the medicinal product to prevent blood clotting in addition to Metalyse, as soon as possible after your chest pain starts. 
Zdravnik vam bo ob zdravilu Metalyse čimprej po pojavu bolečine v prsih, predpisal še zdravilo, ki prepreči nastajanje krvnih strdkov.
Nausea, vomiting 
neznana siljenje na bruhanje, bruhanje
Directly before the solution will be administered, invert the vial with the syringe still attached, so that the syringe is below the vial. 
Tik preden raztopino injiciramo, obrnemo vialo s pritrjeno brizgo tako, da je brizga pod njo.
Prolonged cardiopulmonary resuscitation (> 2 minutes) within the past 2 weeks Acute pericarditis and/or subacute bacterial endocarditis Acute pancreatitis 
• podaljšana kardiopulmonalna reanimacija (> 2 minuti) v preteklih 2 tednih,
Each vial 40 mg tenecteplase. 
Ena viala vsebuje 40 mg tenekteplaze.
Arterial aneurysm and known arterial/venous malformation Neoplasm with increased bleeding risk 
• arterijska anevrizma in znana arterijska ali venska nepravilnost,
Death or permanent disability may occur following bleeding in the brain or other serious bleeding events bleeding in the eyes (eye haemorrhage) 
Srčni zastoj je lahko življenjsko nevaren, notranja krvavitev v trebušni votlini (retroperitonealna krvavitev), krvavitev v možganih (cerebralna hemoragija); krvavitev v možganih in druge resne krvavitve lahko povzročijo smrt ali trajno invalidnost, krvavitev v očeh (očesna hemoragija).
Your doctor will give Metalyse as soon as possible after your chest pain starts as a single dose. 
Zdravnik vam bo vbrizgal zdravilo Metalyse v enem odmerku, kolikor je možno hitro po pojavu bolečine v prsnem košu.
if you have previously had a sudden life-threatening allergic reaction (severe hypersensitivity) to the active ingredient tenecteplase, to gentamicin (a trace residue from the manufacturing process) or any of the other ingredients of Metalyse. 
Zdravila Metalyse vam zdravnik ne bo predpisal če ste v preteklosti imeli nenadno življenjsko nevarno alergijsko reakcijo (hudo preobčutljivost) na učinkovino tenekteplazo, gentamicin (ostanek v sledeh iz proizvodnega postopka) ali katerokoli drugo sestavino zdravila Metalyse.
Very common(may affect more than 1 in 10 people): Low blood pressure (hypotension) Irregular heart beat 
Zelo pogosti (pojavijo se lahko pri več kot 1 od 10 bolnikov): nizek krvni tlak (hipotenzija), neredno bitje srca, bolečina v prsnem košu (angina pektoris).
Significant bleeding disorder either at present or within the past 6 months Patients receiving effective oral anticoagulant treatment, e.g. warfarin sodium (INR > 1.3) (see section 4.4, subsection “Bleeding”) 
• bolniki, ki prejemajo učinkovite peroralne antikoagulante, npr. natrijev varfarinat (INR > 1,3)
Each vial contains 8,000 units (40 mg) tenecteplase. 
Ena viala vsebuje 8.000 enot (40 mg) tenekteplaze.
Body temperature increased Injury, poisoning and procedural complications Not known 
Preiskave redki znižanje krvnega tlaka neznana povečanje telesne temperature Poškodbe in zastrupitve in zapleti pri posegih neznana maščobna embolija, ki ima lahko posledice v prizadetih organih
Each vial 50 mg tenecteplase. 
Ena viala vsebuje 50 mg tenekteplaze.
Metalyse 8,000 units powder and solvent for solution for injection Tenecteplase 
Metalyse 8.000 enot prašek in vehikel za raztopino za injiciranje tenekteplaza
How to store Metalyse 
Kako boste prejeli zdravilo Metalyse
Each vial contains 10,000 units (50 mg) tenecteplase. 
Ena viala vsebuje 10.000 enot (50 mg) tenekteplaze.
Anaphylactoid reaction (including rash, urticaria, bronchospasm, laryngeal oedema) 
Bolezni imunskega sistema redki anafilaktoidna reakcija (vključno z izpuščajem, urtikarijo, bronhospazmom, otekanjem grla)
If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2-8°C. 
Normalno čas hrambe ni daljši od 24 ur, temperatura pa ne višja od 2 do 8 °C.
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Solvent for Metalyse 8,000 U 
IME ZDRAVILA IN POT(I) UPORABE Vehikel za Metalyse 8.000 enot Vehikel za parenteralno uporabo
NAME OF THE MEDICINAL PRODUCT Metalyse 8,000 units powder and solvent for solution for injection 
IME ZDRAVILA Metalyse 8.000 enot prašek in vehikel za raztopino za injiciranje
How to storeMetalyse 
Shranjevanje zdravilaMetalyse
However, the analysis of data from more than 12,000 patients treated during phase I, II and III did not reveal any clinically relevant interactions with medicinal products commonly used in patients with AMI and concomitantly used with tenecteplase. 
in III. faze ni odkrila klinično pomembnih medsebojnih učinkov z zdravili, ki jih običajno dajemo bolnikom z akutnim miokardnim infarktom, kadar so jih prejemali sočasno s tenekteplazo.
1 vial of powder for solution for injection with 40 mg tenecteplase 1 pre-filled syringe with 8 ml of solvent for parenteral use 
FARMACEVTSKA OBLIKA IN VSEBINA 1 viala praška za raztopino za injiciranje s 40 mg tenekteplaze 1 napolnjena injekcijska brizga z 8 ml vehikla za parenteralno uporabo
Metalyse 10,000 units powder and solvent for solution for injection Tenecteplase 
Metalyse 10.000 enot prašek in vehikel za raztopino za injiciranje tenekteplaza
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Solvent for Metalyse 10,000 U 
IME ZDRAVILA IN POT(I) UPORABE Vehikel za Metalyse 10.000 enot Vehikel za parenteralno uporabo
Patency data from the phase I and II angiographic studies suggest that tenecteplase, administered as a single intravenous bolus, is effective in dissolving blood clots in the infarct-related artery of subjects experiencing an AMI on a dose related basis. 
faze kažejo, da tenekteplaza v enkratnem intravenskem bolusu pri bolnikih z akutnim miokardnim infarktom učinkovito in od velikosti odmerka odvisno raztaplja krvne strdke v arteriji, ki jo je prizadel infarkt.
Alternatively the reconstitution can be performed with the included needle. 
Za pripravo raztopine lahko uporabite tudi priloženo iglo.
Each pre-filled syringe contains 8 ml solvent. 
Ena napolnjena injekcijska brizga vsebuje 8 ml vehikla.
Known haemorrhagic diathesis 
• znana hemoragična diateza,
NAME OF THE MEDICINAL PRODUCT Metalyse 10,000 units powder and solvent for solution for injection 
IME ZDRAVILA Metalyse 10.000 enot prašek in vehikel za raztopino za injiciranje
10 ml plastic pre-filled syringe with 8 ml of solvent. 
Napolnjena plastična brizga po 10 ml, ki vsebuje 8 ml vehikla.
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS SYRINGE LABEL FOR SOLVENT 
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
Each pre-filled syringe contains 10 ml solvent. 
Ena napolnjena injekcijska brizga vsebuje 10 ml vehikla.
Metalyse is given by a single injection into a vein by a doctor who is experienced in the use of this type of medicinal product. 
Zdravnik, ki ima s tovrstnimi zdravili izkušnje, vam bo zdravilo Metalyse vbrizgal z eno injekcijo v veno.
When reconstituted with 10 ml solvent each ml contains 1,000 U tenecteplase. 
1 ml raztopine, pripravljene z 10 ml vehikla, vsebuje 1000 enot tenekteplaze.
When reconstituted with 8 ml solvent each ml contains 1,000 U tenecteplase. 
1 ml raztopine, pripravljene z 8 ml vehikla, vsebuje 1000 enot tenekteplaze.
10 ml plastic pre-filled syringe with 10 ml of solvent. 
Napolnjena plastična brizga po 10 ml, ki vsebuje 10 ml vehikla.
STATEMENT OF ACTIVE SUBSTANCE(S) Each vial contains 10,000 units (50 mg) tenecteplase. 
NAVEDBA ENE ALI VEČ UČINKOVIN Ena viala vsebuje 10.000 enot (50 mg) tenekteplaze.
Pulmonary haemorrhage 
redki krvavitev v osrčnik
Remove the tip-cap from the syringe. 
Snamemo zaščito s konice brizge.
internal bleeding in the abdomen (retroperitoneal bleeding) bleeding in the brain (cerebral haemorrhage). 
motnjo krvavitve ali nagnjenost h krvavitvam (hemoragiji), kap (zaplet na možganskem žilju),
No local irritation of the blood vessel was observed after intravenous, intra-arterial or paravenous administration of the final formulation of tenecteplase. 
Po intravenskem, intraarterijskem in paravenskem dajanju končnega pripravka tenekteplaze niso zasledili lokalnega dražečega učinka na žile.
No formal interaction studies with tenecteplase and medicinal products commonly administered in patients with AMI have been performed. 
S tenekteplazo in zdravili, ki jih običajno dajemo bolnikom z akutnim miokardnim infarktom, niso izvedli uradnih študije medsebojnega delovanja.
Reconstitute by swirling gently. 
Raztopino pripravimo z rahlim vrtenjem viale in brizge
Remove the flip-off cap from the vial. 
Brizgo snamemo z nastavka za vialo.
How isMetalyse administered 
Kako bosteprejeli zdravilo Metalyse
Rare(may affect up to 1 in 1,000 people): low blood pressure (hypotension) bleeding in the lungs (pulmonary haemorrhage) hypersensitivity (anaphylactoid reactions) e.g.rash, hives (urticaria), difficulty breathing (bronchospasm) bleeding into the area surrounding the heart (haemopericardium) blood clot in the lung (pulmonary embolism) and in the vessels of other organ systems (thrombotic embolisation) 
Občasni (pojavijo se lahko pri največ 1 od 100 bolnikov): srčni zastoj, težave s srčno zaklopko ali osrčnikom (inkompetenca mitralne zaklopke, perikardialna efuzija), krvni strdek v venah (venska tromboza), tekočina med osrčnikom in srcem (srčna tamponada), pretrganje srčne mišice (ruptura miokarda).
Adjunctive therapy 
Dodatno zdravljenje
Disconnect syringe from the vialadapter. 
NALEPKA NA BRIZGI ZA VEHIKEL
Embolism (thrombotic embolisation) Respiratory, thoracic and mediastinal disorders Common 
Žilne bolezni zelo pogosti krvavitev redki embolija (trombotična embolija) Bolezni dihal, prsnega koša in mediastinalnega prostora pogosti epistaksa redki pljučna krvavitev
Date of first authorisation: 23 September 2009 Date of latest renewal: 14 May 2014 
Datum prve odobritve: 23. september 2009 Datum zadnjega podaljšanja: 14. maj 2014
An occasional use of acetylsalicylic acid (no more than 1000 mg in any 24 hour period)should generally not cause a problem, but prolonged use in other circumstances should be discussed with your doctor. 
Priložnostna uporaba acetilsalicilne kisline (ne več kot 1000 mg v kateremkoli 24-urnem obdobju) na splošno ne bi smelo povzročati težav, vendar pa se morate o daljši uporabi v drugih okoliščinah posvetovati s svojim zdravnikom.
Some other medicines may influence the use of Clopidogrel Krka or vice versa. 
Nekatera druga zdravila lahko vplivajo na jemanje zdravila Klopidogrel Krka in obratno.
You should take Clopidogrel Krka for as long as your doctor continues to prescribe it. 
Zdravilo Klopidogrel Krka morate jemati, dokler vam ga vaš zdravnik predpisuje.
7 film-coated tablets: EU/1/09/556/001 14 film-coated tablets: EU/1/09/556/002 28 film-coated tablets: EU/1/09/556/003 30 film-coated tablets: EU/1/09/556/004 50 film-coated tablets: EU/1/09/556/005 56 film-coated tablets: EU/1/09/556/006 60 film-coated tablets: EU/1/09/556/010 84 film-coated tablets: EU/1/09/556/007 90 film-coated tablets: EU/1/09/556/008 100 film-coated tablets: EU/1/09/556/009 112 film-coated tablets: EU/1/09/556/012 120 film-coated tablets: EU/1/09/556/011 
7 filmsko obloženih tablet: EU/1/09/556/001 14 filmsko obloženih tablet: EU/1/09/556/002 28 filmsko obloženih tablet: EU/1/09/556/003 30 filmsko obloženih tablet: EU/1/09/556/004 50 filmsko obloženih tablet: EU/1/09/556/005 56 filmsko obloženih tablet: EU/1/09/556/006 60 filmsko obloženih tablet: EU/1/09/556/010 84 filmsko obloženih tablet: EU/1/09/556/007 90 filmsko obloženih tablet: EU/1/09/556/008 100 filmsko obloženih tablet: EU/1/09/556/009 112 filmsko obloženih tablet: EU/1/09/556/012 120 filmsko obloženih tablet: EU/1/09/556/011
Clopidogrel Krka with food and drink Clopidogrel Krka may be taken with or without food. 
Zdravilo Clopidogrel Krka skupaj s hrano in pijačo Zdravilo Clopidogrel Krka lahko jemljete s hrano ali brez nje.
If you experience prolonged bleeding when taking Clopidogrel Krka If you cut or injure yourself, it may take longer than usual for bleeding to stop. 
Če doživite podaljšanje krvavitve v času jemanja zdravila Klopidogrel Krka Če se urežete ali poškodujete, lahko traja dlje kot običajno, da se krvavitev ustavi.
7 film-coated tablets 14 film-coated tablets 28 film-coated tablets 30 film-coated tablets 50 film-coated tablets 56 film-coated tablets 60 film-coated tablets 84 film-coated tablets 90 film-coated tablets 100 film-coated tablets 112 film-coated tablets 120 film-coated tablets 
7 filmsko obloženih tablet 14 filmsko obloženih tablet 28 filmsko obloženih tablet 30 filmsko obloženih tablet 50 filmsko obloženih tablet 56 filmsko obloženih tablet 60 filmsko obloženih tablet 84 filmsko obloženih tablet 90 filmsko obloženih tablet 100 filmsko obloženih tablet 112 filmsko obloženih tablet 120 filmsko obloženih tablet
Clopidogrel Krka 75 mg 
Klopidogrel Krka 75 mg
This benefit was mostly driven by the statistically significant reduction in the incidence of MI [287 (4.6%) in the clopidogrel-treated group and 363 (5.8%) in the placebo-treated group]. 
Ta korist je bila v glavnem zaradi statistično pomembnega zmanjšanja incidence MI [287 (4,6 %) v skupini, zdravljeni s klopidogrelom, in 363 (5,8 %) v skupini s placebom].
What you need to know before you take Clopidogrel Krka 
Kaj morate vedeti, preden boste vzeli zdravilo Klopidogrel Krka
You should have been told that ‘oral anticoagulants' are more effective than acetylsalicylic acid or the combined use of Clopidogrel Krka and acetylsalicylic acid for this condition. 
Povedati so vam morali, da so "peroralni antikoagulanti" pri tej motnji učinkovitejši kot acetilsalicilna kislina ali kombinirana uporaba zdravila Klopidogrel Krka in acetilsalicilne kisline.
Your doctor should have prescribed Clopidogrel Krka plus acetylsalicylic acid if you cannot take ‘oral anticoagulants' and you do not have a risk of major bleeding. 
Zdravnik naj bi vam predpisal zdravilo Klopidogrel Krka skupaj z acetilsalicilno kislino, če ne morete prejemati "peroralnih antikoagulantov", ali če nimate tveganja za večjo krvavitev.
ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. 
(od 7 dni do manj kot 6 mesecev) ali dokazano periferno arterijsko boleznijo.
- carbamazepine a medicine to treat some forms of epilepsy, - moclobemide, medicine to treat depression, - repaglinide, medicine to treat diabetes, - paclitaxel, medicine to treat cancer, - anti-retroviral medicines (medicines to treat HIV infections). 
- karbamazepin, zdravilo za zdravljenje nekaterih oblik epilepsije, - moklobemid, zdravila za zdravljenje depresije, - repaglinid, zdravilo za zdravljenje sladkorne bolezni, - paklitaksel, zdravilo za zdravljenje raka, - protiretrovirusna zdravila (zdravila za zdravljenje okužbe z virusom HIV).
- Active pathological bleeding such as peptic ulcer or intracranial haemorrhage. 
- Aktivna patološka krvavitev, npr. peptična razjeda ali intrakranialna krvavitev.
If you think any of these apply to you, or if you are in any doubt at all, consult your doctor before taking Clopidogrel Krka. 
Če menite, da se karkoli od navedenega nanaša na vas, ali če ste kakorkoli v dvomih, se posvetujte s svojim zdravnikom, preden vzamete zdravilo Klopidogrel Krka.
Then, the recommended dose is one 75 mg tablet of Clopidogrel Krka per day as described above. 
Nato je priporočeni odmerek ena 75-mg tableta zdravila Klopidogrel Krka na dan, kot je opisano zgoraj.
- Hypersensitivity to the active substance or to any of the excipients listed in section 2 or section 
- Preobčutljivost na učinkovino ali katero koli pomožno snov, navedeno v poglavju 2 ali v poglavju 6.1.
If you have experienced severe chest pain (unstable angina or heart attack), you may be prescribed Clopidogrel Krka in combination with acetylsalicylic acid, a substance present in many medicines used to relieve pain and lower fever. 
Če ste doživeli hudo bolečino v prsih (nestabilna angina pektoris ali srčni napad), so vam morda predpisali zdravilo Klopidogrel Krka v kombinaciji z acetilsalicilno kislino, učinkovino, ki je prisotna v številnih zdravilih, ki se uporabljajo za lajšanje bolečine in zniževanje zvišane telesne temperature.
Driving and using machines Clopidogrel Krka is unlikely to affect your ability to drive or to use machines. 
Vpliv na sposobnost upravljanja vozil in strojev Ni verjetno, da bi zdravilo Klopidogrel Krka vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
If you are pregnant or suspect that you are pregnant, you should tell your doctor or your pharmacist before taking Clopidogrel Krka. 
Če ste noseči ali mislite, da ste noseči, morate o tem obvestiti svojega zdravnika ali farmacevta, preden vzamete zdravilo Klopidogrel Krka.
If you take more Clopidogrel Krka than you should Contact your doctor or the nearest emergency department because of the increased risk of bleeding. 
Če ste vzeli večji odmerek zdravila Klopidogrel Krka, kot bi smeli Zaradi povečanega tveganja za krvavitev se posvetujte s svojim zdravnikom ali z medicinskim osebjem na najbližjem bolnišničnem oddelku za nujno zdravniško pomoč.
• If you are allergic to clopidogrel or any of the other ingredients of this medicine (listed in section 6). 
Ne jemljite zdravila Klopidogrel Krka - če ste alergični na klopidogrel ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
What Clopidogrel Krka looks like and contents of the pack The film-coated tablets are pink, round and slightly convex. 
Izgled zdravila Klopidogrel Krka in vsebina pakiranja Filmsko obložente tablete so rožnate, okrogle in rahlo izbočene.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including medicines obtained without a prescription. 
Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo.
What Clopidogrel Krka is and what it is used for 
Kaj je zdravilo Klopidogrel Krka in za kaj ga uporabljamo
Other medicines and Clopidogrel Krka 
Druga zdravila in zdravilo Klopidogrel Krka
If you become pregnant while taking Clopidogrel Krka, consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant. 
Če med zdravljenjem z zdravilom Klopidogrel Krka zanosite, se takoj posvetujte s svojim zdravnikom, saj jemanje klopidogrela med nosečnostjo ni priporočljivo.
If you forget to take Clopidogrel Krka 
Če ste pozabili vzeti zdravilo Klopidogrel Krka
The recommended dose, including for patients with a condition called ‘atrial fibrillation' (an irregular heartbeat), is one 75 mg tablet of Clopidogrel Krka per day to be taken orally with or without food, and at the same time each day. 
Priporočeni odmerek, vključno za bolnike, ki imajo bolezensko stanje, imenovano "atrijska fibrilacija" (nepravilen srčni utrip), je ena 75 mg tableta zdravila Klopidogrel Krka na dan, ki jo lahko vzamete s hrano ali brez nje; odmerek morate jemati vsak dan ob istem času.
Clopidogrel is indicated in: - Adult patients suffering from myocardial infarction (from a few days until less than 35 days), 
Sekundarno preprečevanje aterotrombotičnih dogodkov Klopidogrel je indiciran pri: - odraslih bolnikih z miokardnim infarktom (od nekaj dni do manj kot 35 dni), ishemično kapjo
Blister of OPA/Alu/PVC-Alu containing 7, 14, 28, 30, 50, 56, 60, 84, 90, 100, 112 and 120 filmcoated tablets in the box. 
Na voljo so v pretisnih omotih (OPA/Al/PVC-Al) po 7, 14, 28, 30, 50, 56, 60, 84, 90, 100, 112 in 120 filmsko obloženih tablet v škatli.
Boxes of 7, 14, 28, 30, 50, 56, 60, 84, 90, 100, 112 and 120 film-coated tablets in blisters are available. 
Na voljo so v pretisnih omotih po 7, 13, 28, 30, 50, 56, 60, 84, 90, 100, 112 in 120 filmsko obloženih tablet v škatli.
• You should tell your doctor if a surgery (including dental) is planned. 
Ko jemljete zdravilo Klopidogrel Krka: - morate zdravniku povedati, če imate predvideno kakšno operacijo (tudi zobozdravstveni poseg).
You have been prescribed Clopidogrel Krka to help prevent blood clots and reduce the risk of these severe events because: - You have a condition of hardening of arteries (also known as atherosclerosis), and - You have previously experienced a heart attack, stroke or have a condition known as peripheral arterial disease, or - You have experienced a severe type of chest pain known as ‘unstable angina' or ‘myocardial infarction' (heart attack). 
Zdravilo Klopidogrel Krka vam je predpisano za pomoč pri preprečevanju nastajanja krvnih strdkov in za zmanjšanje tveganja teh hudih dogodkov, ker: - imate otrdele arterije (znano tudi kot ateroskleroza) in - ste predhodno doživeli srčni napad, kap ali imeli stanje, ki je znano kot periferna arterijska bolezen ali.
- Adult patients suffering from acute coronary syndrome: - Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA). 
- odraslih bolnikih z akutnim koronarnim sindromom: - akutni koronarni sindrom brez elevacije ST spojnice (nestabilna angina ali miokardni infarkt brez Q zobca), vključno z bolniki, katerim je bil vstavljen stent po perkutani koronarni intervenciji, v kombinaciji z acetilsalicilno kislino (ASA - acetylsalicylic acid).
What Clopidogrel Krka contains - The active substance is clopidogrel. 
Kaj vsebuje zdravilo Klopidogrel Krka - Učinkovina je klopidogrel.